Lexology February 1, 2024
Knobbe Martens

A recent paper published by market.us projects that the Deep Brain Stimulation (DBS) devices market is expected to reach around $3.5 Billion by 2033, compared to the projected $1.5 Billion for 2024.

DBS systems can be used for treatment of Parkinson’s disease and other movement disorders. They can include a device that sends electrical signals through wire electrodes implanted in the brain, similar to how a cardiac pacemaker sends electrical signals to the heart. DBS systems interrupt the irregular signals that cause tremors and other movement symptoms when they are successfully implemented. Doctors have used DBS systems to treat movement disorders or neuropsychiatric conditions when medications have become less effective.

According to market.us, the growing number of neurological disorders such...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Medical Devices
Boston Scientific to acquire SoniVie for $540 million, expand hypertension treatment portfolio
Medicare Coverage Of Medical Technologies In A New Era
This year's top congressional medical technology priorities
Boston Scientific to acquire devicemaker: 3 things to know
Everything You Need To Know Before Getting An RFID Implant - 3

Share This Article